Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Certolizumab pegol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cimzia 200mg/1ml solution for injection pre-filled syringes
1001030Y0BBAAAA
|
Cimzia | Certolizumab pegol | Musculoskeletal and Joint Diseases | 1 |
|
Certolizumab pegol 200mg/1ml inj cartridges
1001030Y0AAACAC
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Certolizumab pegol 200mg/1ml inj pf disposable devices
1001030Y0AAABAB
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Certolizumab pegol 200mg/1ml inj pre-filled syringes
1001030Y0AAAAAA
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Cimzia 200mg/1ml inj in a dose-dispenser cartridge
1001030Y0BBACAC
|
Cimzia | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Cimzia 200mg/1ml solution for injection pre-filled pens
1001030Y0BBABAB
|
Cimzia | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.